PCSK9
Sort by:
UPMC
Risky Business – Accurately Assessing Cardiac Risk and Acting Accordingly
FEATURING
Eric Dueweke
- 203 views
- July 5, 2024
- 2
Cedars Sinai
Somethings Old, Somethings New: Cholesterol Management in 2024
FEATURING
Martha Gulati
- 2,800 views
- June 4, 2024
- 20
Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes
Lipoprotein(a) in 2024
FEATURING
Harpreet Bhatia
- 443 views
- May 17, 2024
- 7
Canadian Collaborative Research Network
The Disruptive Science of LDL-Lowering: From Statins to PCSK9 Manipulation
FEATURING
Milan Gupta
- 1,563 views
- May 14, 2024
- 13
ACC 2024 Insights
ACC 2024 Insights: Is Bempedoic Acid a Useful Alternative to PCSK9 Inhibitors?
FEATURING
Stephen Nicholls
- 1,119 views
- April 26, 2024
- 7
ACC 2024 Insights
ACC 2024 Insights: What Should I Do About an Elevated Lp(a) Based on Current Evidence and Available Treatments?
FEATURING
Raul Santos
- 1,140 views
- April 16, 2024
- 8
ACC 2024 Insights
ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!
FEATURING
Samia Mora
- 3,686 views
- April 11, 2024
- 33
MUSC Cardiology
Big Questions About Lipoprotein “Little” (a)
FEATURING
Ashley Arana Waring
- 3,410 views
- March 29, 2024
- 36
MUSC Cardiology
Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients
FEATURING
Pamela B. Morris
- 875 views
- March 29, 2024
- 8
MUSC Cardiology
Complex Case Discussion: Familial Hypercholesterolemia
FEATURING
Kellie Mclain,
Pamela B. Morris,
Ashley Arana Waring,
Marc-André Cornier,
Matthew Budoff,
Jan Basile
- 28 views
- March 29, 2024
MUSC Cardiology
Complex Case Discussion: Dyslipidemia Management
FEATURING
Kellie Mclain,
Pamela B. Morris,
Ashley Arana Waring,
Marc-André Cornier,
Matthew Budoff,
Jan Basile
- 42 views
- March 29, 2024
MUSC Cardiology
The Top Clinical Trials in Preventive Cardiology: VERVE 101
FEATURING
Martha Gulati
- 107 views
- March 29, 2024
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Defining and Treating Dyslipidemia
FEATURING
Michael J. Wilkinson
- 1,469 views
- March 6, 2024
- 12
Penn Medicine Heart and Vascular Center
Lipoprotein(a) and Cardiovascular Risks: New Insights
FEATURING
Vera Bittner
- 2,234 views
- December 19, 2023
- 11
Jefferson Health
Advanced Testing and Lifestyle Modifications in the Cardiac Patient: An Integrative Approach
FEATURING
Alaina King
- 34 views
- November 24, 2023
Penn Medicine Heart and Vascular Center
Treatments for CV Risk Reduction: Clinical Case Discussion
- 100 views
- November 21, 2023
- 1
Penn Medicine Heart and Vascular Center
Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?
FEATURING
Archna Bajaj
- 559 views
- November 21, 2023
- 2
Integrity CE
Cross-Setting Strategies for Improved Management of Homozygous Hypercholesterolemia in Cardiology Settings
FEATURING
Mary Mcgowan
- 34 views
- November 3, 2023
Michael Albosta
Inclisiran for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
- 1,125 views
- October 11, 2023
- 6
The Texas Heart Institute
Non-Statin Therapies, Expert ACC Consensus
FEATURING
Christie Ballantyne
- 1,283 views
- September 7, 2023
- 10
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
FEATURING
Icilma Fergus
- 13,615 views
- September 5, 2023
- 103
Complex Coronary Cases
LIVE Round Table: Panel Discussion on Lipid Management
FEATURING
Roxana Mehran
- 98 views
- August 31, 2023
- 2